Table 12.
Misdiagnosed cases. Estimates for the USA.
| Disease | % LD | Year | Prevalence | Comment | Reference |
|---|---|---|---|---|---|
| MS | 2010 | 727,344 | Wallin et al. (2019) | ||
| Lyme cases | 19% | Note 1 | 140,377 | Low CI 95% used | Chmielewska-Badora, Cisak, and Dutkiewicz (2000) |
| Alzheimer’s disease | 2010 | 4,700,000 | Hebert, Weuve, Scherr, and Evans (2013) | ||
| Lyme cases | 19% | 906,824 | Mean of 10 studies | See textSection 6 | |
| ME/CFS | 2,736,000 | Valdez et al. (2019) | |||
| Lyme cases | 10% | Note 2 | 273,600 | Bloor survey 48% CFS | Bloor (2014) |
| Total Misdiagnosed | 1,320,801 | ||||
| Undiagnosed | 30% | 396,240 | Bloor survey | Bloor (2014) | |
| Total un/misdiagnosed | 1,717,041 | ||||
Note 1. For MS related Lyme cases rather than using the Chmielewska-Badora mean data a highly conservative lower 95% confidence value is used.
Note 2. For ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) cases a conservative estimate of 10% is used rather than the 48% of Lyme patients given a CFS diagnosis.